STOCK PURCHASE AGREEMENT
EXHIBIT
10.65
Redacted
Version
This
Stock Purchase Agreement (this “Agreement”),
dated
December 31, 2007, is by and among (i) ArthroCare
Corporation, a Delaware corporation (“Buyer”),
(ii)
DiscoCare, Inc., a Delaware corporation (the
“Company”),
and
(iii) Xxxxxxxx Xxxxxx, D.P.M., the sole stockholder of the Company (the
“Seller”
and,
together with the Company, the “Seller
Parties”
and,
together with Buyer, the “Parties”).
RECITALS
A. Seller
owns all
of the Company’s outstanding Common Stock, no par value per share (the
“Shares”).
B. Buyer
desires to purchase from Seller all of the Shares, and Seller desires to sell
to
Buyer all of the Shares, in accordance with this Agreement’s terms and
conditions.
AGREEMENT
NOW,
THEREFORE, in consideration of the premises, the respective representations,
warranties, covenants and agreements contained in this Agreement, and other
good
and valuable consideration the receipt and sufficiency of which are hereby
acknowledged, and intending to be legally bound, the Parties agree as
follows:
ARTICLE
1
PURCHASE
AND SALE OF SHARES
1.1 Purchase
and Sale of Shares.
On and
subject to the terms and conditions of this Agreement, Buyer hereby purchases
from Seller, and Seller hereby sells to Buyer, all of the Shares for the
consideration specified in Section
1.2.
1.2 Purchase
Price.
The
aggregate purchase price for the Shares (the “Purchase
Price”)
is
$25,000,000. Buyer shall pay to the Seller the Purchase Price in cash, less
the
Escrow Amount (defined below), upon the execution and delivery of this Agreement
by all Parties (the “Closing”).
The
date of the Closing shall hereinafter be referred to as the “Closing
Date.”
1.3 Deliveries.
On the
Closing Date,
(a) Seller
shall deliver, or caused to be delivered, to Buyer: (i) certificates
representing the Shares, duly endorsed (or accompanied by duly executed stock
powers), (ii) an officer’s certificate and a secretary’s certificate for the
Company, each duly executed by the appropriate person, (iii) the resignation,
effective as of the Closing, of each of the Company’s directors and officers,
(iv) the
consents set forth on Schedule
3.3,
(v) the
**** Agreement in the form attached hereto as Schedule
1.3(a);
(vi)
the Escrow Agreement (defined below), duly executed by Seller, (vii) an
assignment of all of the Company’s Receivables which arose prior to ****
(“Seller’s
Receivables”),
a
list of which is attached as Schedule
4.5,
to
Seller
and (viii) other
documents as mutually agreed to by the Parties.
(b) Buyer
shall
deliver,
or
cause
to be
delivered, to the Seller: (i) the Purchase Price
in
cash,
less
the Escrow Amount
payable
by wire transfer of immediately available funds,
(ii) an
officer’s certificate and assistant secretary’s certificate for Buyer, each duly
executed by the appropriate person,
(iii)
the Escrow Agreement, duly executed by Buyer, (iv)
the
Release Agreement in the form attached hereto as Schedule
1.3(a);
and
(v)
other
documents as mutually
agreed to by the Parties.
(c) Buyer
shall pay the Escrow Amount (as defined in Section
5.6)
to the
Escrow Agent in cash payable by wire transfer of immediately available
funds.
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
1
ARTICLE
2
REPRESENTATIONS
AND WARRANTIES CONCERNING THE TRANSACTION
2.1 Representations
and Warranties of Seller.
Seller
represents and warrants to Buyer that the statements contained in this
Section
2.1
are
correct and complete on the Closing Date.
(a) Power
and Authority; Enforceability.
Seller
has the requisite competence and authority to execute and deliver this
Agreement, each writing executed or delivered in connection with this Agreement
and each amendment or supplement to any of the foregoing (including this
Agreement, the “Transaction
Documents”)
to
which Seller or any of Seller’s Affiliates (as defined below) is a party, and to
perform and to consummate the transactions contemplated hereby and thereby
(the
“Transactions”).
Each
Transaction Document to which a Seller Party is a party has been duly executed
and delivered by such Seller Party, and is enforceable against such Seller
Party
in accordance with its terms except as such enforceability may be subject to
the
effects of bankruptcy, insolvency, moratorium or other Laws relating to or
affecting the rights of creditors and remedies and general principles of equity,
including principles of commercial reasonableness, good faith and fair dealing
(the “Enforceability
Exception”).
An
“Affiliate”
of
a
specified person shall mean a person that directly, or indirectly through one
or
more intermediaries, controls or is controlled by, or is under common control
with, the person specified.
(b) No
Violation; Necessary Approvals. Except
as
listed on Schedule
2.1,
the
execution and the delivery by Seller of this Agreement and the other Transaction
Documents to which Seller is a party, the performance by Seller of Seller’s
obligations hereunder and thereunder, and the consummation of the Transactions
by Seller will not (i) with or without notice or lapse of time, constitute,
create or result in a breach or violation of, default under, loss of any
material benefit or right under or acceleration of performance of any obligation
required under any (A) law (statutory, common or otherwise), constitution,
ordinance, rule, regulation, executive order or other similar authority
(“Law”)
applicable to the Seller Parties enacted, adopted, promulgated or applied by
any
legislature, agency, bureau, branch, department, division, commission, court,
tribunal or other similar recognized organization or body of any federal, state,
county, municipal, local or foreign government or other similar recognized
organization or body exercising similar powers or authority (a “Governmental
Body”),
(B)
order, ruling, decision, award, judgment, injunction or other similar
determination or finding by, before or under the supervision of any Governmental
Body or arbitrator (an “Order”),
(C)
contract, agreement, arrangement, commitment, instrument, document or similar
understanding (whether written or oral), including a lease, sublease and rights
thereunder (“Contract”)
or
permit, license, certificate, waiver, notice and similar authorization
(“Permit”)
to
which, in the case of (A), (B) or (C), any Seller Party is a party or by which
it is bound or any of its assets are subject, or (D) any provision of the
organizational documents of Company as in effect on the Closing Date; (ii)
result in the imposition of any lien, claim or encumbrance (an “Encumbrance”)
upon
any assets (including the Shares) owned by Seller; (iii) require any consent
under any Contract or organizational document to which any Seller Party is
a
party or by which it is bound or any of its assets are subject; (iv) require
any
Permit under any Law or Order other than notifications or other filings with
state or federal regulatory agencies after the Closing that are necessary or
convenient and do not require approval of the agency as a condition to the
validity of the Transactions; or (v) trigger any rights of first refusal,
preferential purchase or similar rights with respect to any of the
Shares.
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
2
(c) Brokers’
Fees.
Seller
has no liability or obligation to pay any compensation to any broker, finder
or
agent with respect to the Transactions for which Buyer or the Company could
become directly or indirectly liable.
(d) Shares;
Seller Information.
Seller
holds of record and owns beneficially all of the capital stock of the Company,
free and clear of any Encumbrances (other than any restrictions on transfer
under the Securities Act of 1933 (the “Securities
Act”)
and
state securities Laws). The
signature page to this Agreement sets
forth the address and state of residence of Seller as of the date hereof. Seller
is not a party to any Contract (other than this Agreement) that could require
Seller to sell, transfer, or otherwise dispose of any capital stock of the
Company. Seller is not a party to any other Contract with respect to any capital
stock of the Company.
2.2 Representations
and Warranties of Buyer.
Buyer
represents and warrants to the Seller Parties that the statements contained
in
this Section
2.2
are
correct and complete on the Closing Date.
(a) Organization
of Buyer.
Buyer is
an entity duly organized, validly existing and in good standing under the Laws
of the State of Delaware. Buyer has the relevant entity power and authority
necessary to own or lease its properties and to carry on its businesses as
currently conducted. There is no pending or (to Buyer’s knowledge) threatened
action, appeal, petition, plea, charge, complaint, claim, suit, demand,
litigation, arbitration, mediation, hearing, inquiry, investigation or similar
event, occurrence, or proceeding (an “Action”)
for
the dissolution, liquidation, insolvency or rehabilitation of
Buyer.
(b) Power
and Authority; Enforceability.
Buyer
has the relevant entity power and authority necessary to execute and deliver
each Transaction Document to which it is a party and to perform and consummate
the Transactions. Buyer has taken all action necessary to authorize its
execution and delivery of each Transaction Document to which Buyer is a party,
the performance of its obligations thereunder and its consummation of the
Transactions. Each Transaction Document to which Buyer is a party has been
duly
authorized, executed and delivered by Buyer and is enforceable against Buyer
in
accordance with its terms, subject to the Enforceability Exception.
(c) No
Violation; Necessary Approvals.
The
execution and the delivery by Buyer of this Agreement and the other Transaction
Documents to which Buyer is a party, the performance by Buyer of its obligations
hereunder and thereunder and the consummation of the Transactions by Buyer
will
not (i) with or without notice or lapse of time, constitute, create or result
in
a breach or violation of, default under, loss of benefit or right under or
acceleration of performance of any obligation required under any Law, Order,
Contract or Permit to which Buyer is a party or by which it is bound or any
of
its assets are subject, or any provision of Buyer’s organizational documents as
in effect on the Closing Date, (ii) require any consent under any Contract
or organizational document to which Buyer is a party or by which it is bound;
or
(iii) require any Permit under any Law or Order other than (A) required filings,
if any, with the Securities and Exchange Commission and (B) notifications or
other filings with state or federal regulatory agencies after the Closing that
are necessary or convenient and do not require approval of the agency as a
condition to the validity of the Transactions
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
3
(d) Brokers’
Fees.
Buyer
has no liability or obligation to pay any compensation to any broker, finder
or
agent with respect to the Transactions.
(e) Litigation.
There
are no legal or similar proceedings pending, or, to the knowledge of Buyer,
threatened against Buyer or to which Buyer is a party relating to this Agreement
or the Transactions.
ARTICLE
3
REPRESENTATIONS
AND WARRANTIES CONCERNING THE COMPANY
Each
Seller Party, jointly and severally, represents and warrants to Buyer that
the
statements contained in this ARTICLE
3
are
correct and complete on the Closing Date, except as set forth in the schedules
the Seller Parties delivered to Buyer on the Closing Date.
3.1 Organization
of Company.
The
Company (a) is a corporation duly organized, validly existing and in good
standing under the Laws of the State of Delaware, (b) is duly qualified to
do
business as a foreign corporation and is in good standing under the Laws of
each
jurisdiction in which either the ownership or use of the properties owned or
used by it, or the nature of the activities conducted by it, requires such
qualification, (c) has the relevant entity power and authority necessary to
own
or lease its properties and to carry on its businesses as currently conducted
and (d) is not in breach or violation of, or default under, any provision of
its
organizational documents. The Company has never approved or taken any action,
nor is there any pending or (to any Seller Party’s knowledge) threatened Action,
seeking or otherwise contemplating the Company’s dissolution, liquidation,
insolvency or rehabilitation. The Company owns no interest in any subsidiary,
consolidated or otherwise.
3.2 Power
and Authority; Enforceability.
The
Company has the requisite power and authority necessary to execute and deliver
each Transaction Document to which it is a party and to perform and consummate
the Transactions. The Company has taken all action necessary to authorize the
execution and delivery by it of each Transaction Document to which it is a
party, the performance of its obligations thereunder, and the consummation
by
the Company of the Transactions. Each Transaction Document to which the Company
is a party has been duly authorized, executed and delivered by the Company
and
is enforceable against the Company in accordance with its terms, subject to
the
Enforceability Exception.
3.3 No
Violation; Necessary Approvals.
Except
as listed on Schedule
3.3,
the
execution and the delivery by Company of this Agreement and the other
Transaction Documents to which the Company is a party, the performance by the
Company of its obligations hereunder and thereunder and the consummation of
the
Transactions by the Company will not (a) with or without notice or lapse of
time, constitute, create or result in a breach or violation of, default under,
loss of benefit or right under or acceleration of performance of any obligation
required under any Law, Order, Contract or Permit to which the Company is a
party or by which it is bound or any of its assets are subject, or under any
provision of the Company’s organizational documents as in effect on the Closing
Date, (b) require any consent under any Contract or organizational document
to
which the Company is a party or by which it is bound or any of its assets are
subject, (c) require any Permit under any Law or Order other than (i) required
filings, if any, with the SEC and (ii) notifications or other filings with
state
or federal regulatory agencies after the Closing that are necessary or
convenient and do not require approval of the agency as a condition to the
validity of the Transactions, (d) trigger any rights of first refusal,
preferential purchase or similar rights or (e) subject the Company or its assets
to any Tax (as defined in Section 3.10).
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
4
3.4 Capitalization.
The
Company’s authorized capital stock consists of One Thousand Five Hundred (1,500)
shares of Common Stock, no par value per share, of which One Hundred (100)
shares are issued and outstanding and no shares are held in treasury. All of
the
issued and outstanding Shares: (a) have been duly authorized and are validly
issued, fully paid, and nonassessable, (b) were issued in compliance with all
applicable state and federal securities Laws, (c) were not issued in breach
or
violation of, or did not cause as a result of the issuance thereof a default
under, any Contract with or right granted to any other person and (d) are held
of record and
owned
beneficially
by the
Seller. The Company has no outstanding options, warrants, exchangeable or
convertible securities, subscription rights, exchange rights, statutory
pre-emptive rights, preemptive rights granted under the Company’s organizational
documents, stock appreciation rights, phantom stock, profit participation or
similar rights, or any other right or instrument pursuant to which any person
may be entitled to purchase any security of the Company, and has no obligation
to issue any rights or instruments. There are no Contracts with respect to
the
voting or transfer of any of the Company’s capital stock. The Company is not
obligated to redeem or otherwise acquire any of its outstanding capital
stock.
3.5 Records.
The
copies of the Company’s organizational documents that were provided to Buyer are
accurate and complete and reflect all amendments made through the date hereof.
The Company’s minute books and other records made available to Buyer for review
were correct and complete as of the date of such review, no further entries
have
been made through the date of this Agreement, such minute books and records
contain the true signatures of the persons purporting to have signed
them.
3.6 Financial
Information. Set
forth
on Schedule
3.6
is the
financial
information of
the
Company that was provided to the Buyer on December 19, 2007 (the
“Financial
Information”).
The
Financial Information presents fairly on a cash basis the Company’s receipts and
disbursements for such periods and are consistent with the Company’s books and
records.
3.7 Subsequent
Events.
Except
as set forth in Schedule
3.7,
since
December 1, 2007, the Company has operated in the ordinary course of business
consistent with past custom and practice (including with respect to quantity,
quality and frequency) (“Ordinary
Course of Business”),
and
there have been no events, series of events, or the lack of occurrence thereof
that, singularly or in the aggregate, could reasonably be expected to have
a
material adverse effect, either individually or in the aggregate, on the
Company’s business, operations, condition (financial or otherwise), properties,
assets, liabilities, rights, obligations or prospects.
3.8 No
Undisclosed Liabilities.
The
Company does not have any liability or obligation (and, to each Seller Party’s
knowledge, there is no basis for any present or future Action or Order against
the Company giving rise to any material liability or obligation), except for
(a)
liabilities due
to
Buyer with respect to the purchase of inventory from Buyer and its Affiliates,
(b) liabilities reflected
or reserved against in the Financial Information and not paid or discharged
prior to Closing and (c)
liabilities not reflected or reserved against in the Financial Information
which
do not (i) result from or relate to any tort, infringement, breach, violation
of
or default under any Law, Order, Permit or Contract; (ii) arise out of any
Action or Order or (iii) exceed $25,000 individually or in the aggregate. The
Company has no liability or obligation to pay any compensation to any broker,
finder or agent with respect to the Transactions for which Buyer could become
directly or indirectly responsible.
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
5
3.9 Legal
Compliance.
(a) The
Company and each of its predecessors and Affiliates has complied with all
applicable
Laws and Orders, and no Action is pending or, to each Seller Party’s knowledge,
threatened against any of them alleging any failure to so comply. No material
expenditures are, or based on any Law, Order or Permit will be, required of
the
Company or Buyer for the Company and its business and operations to remain
in
compliance with all Laws, Orders and Permits immediately following the Closing.
“Affiliate”
with
respect to a specified person means any other person who, directly or
indirectly, through one or more intermediaries, controls or is controlled by,
or
is under common control with, the specified person.
(b) None
of
the Seller Parties has ordered, referred, or requested, directly or indirectly,
any items or services from the Company that are subject or entitled to
reimbursement in whole or in part by, nor have any of the Seller Parties
submitted any claims for reimbursement to, Medicare, Medicaid or any other
state
or federal healthcare reimbursement program.
(c) Without
limiting the generality of the foregoing, the Company is in material compliance
with all conditions and standards for participation in the Medicare, Medicaid
and TriCare programs. The Company is not operating any aspect of its business
under or subject to a plan of correction or corporate integrity agreement with
a
governmental agency or entity. Neither the Seller nor the Company, nor any
employees of the Company, are excluded, suspended, debarred or otherwise
ineligible from participation in Federal healthcare programs. Each Seller Party
is in compliance, to the extent applicable, with all federal and state laws
governing commercial or private third-party payor payments for healthcare
services.
(d) The
Company operates solely as a sales agent of U.S. medical devices manufactured
by
Buyer and its Affiliates. The Company has been and is in compliance with all
applicable statutes, regulations and policies, if any, of the FDA, the Center
for Medicare and Medicaid Services, state regulatory agencies and the TriCare
program.
(e) Without
limiting the generality of the foregoing, no Seller Party has given or received
in violation of any Law any payments or any other remuneration, either directly
or indirectly, overtly or covertly, in cash or in kind, in return for receiving
or making referrals for the furnishing or arranging for the furnishing of any
item or service, or in return for purchasing, leasing, ordering, or arranging
for or recommending purchasing, leasing, or ordering any good, facility, service
or item in violation of 42 U.S.C. §1320a 7a and 1320a 7b, commonly known as the
“Anti Kickback Statute.” In addition, the Company has not accepted any referral
for the provision of any designated health service, or submitted a claim for
payment to Medicare or Medicaid for the provision of such services, in violation
of 42 U.S.C. §1395nn, commonly known as the “Xxxxx Act” or “Xxxxx II.” No Seller
Party has engaged in practices violating the Federal False Claims Act (31 U.S.C.
§§3729-3730), HIPAA (defined below) fraud and abuse provisions (18 U.S.C.
§1347), and the Civil Monetary Penalties Act (42 U.S.C. §1320a-7a(a), including
but not limited to, fraudulent coding practices and the presentation of
otherwise fraudulent claims. There have been no compliance concerns found to
be
substantiated.
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
6
(f) Without
limiting the generality of the foregoing, to the extent applicable to the
Company, the Company, in its ordinary business operation, has complied and
is
currently in compliance with the requirements of the Health Insurance
Portability and Accountability Act of 1996 (“HIPAA”)
and
its implementing regulations and with the requirements of all applicable state
regulations implementing Title V of the Xxxxx-Xxxxx-Xxxxxx Act (“GLB”)
that
are applicable to the Company’s relationship with any Business Associate (as
such term is defined in HIPAA and/or GLB). To the extent that the Company has
access to Protected Health Information (as such term is defined in HIPAA and/or
GLB, “PHI”),
and
except as necessary to complete the transactions contemplated by this Agreement
or for internal management and compliance purposes, the Company has not and
shall not use or further disclose PHI other than as permitted or required by
HIPAA or as required by Law.
3.10 Taxes.
The
Company has no unpaid liability or obligation for any federal, state, local,
or
foreign income, gross receipts, license, payroll, employment, excise,
occupation, customs, ad valorem, duties, franchise, withholding, social
security, unemployment, real property, personal property, sales, use, transfer,
registration, estimated or other tax of any kind whatsoever, including any
interest, penalty or addition thereto, whether disputed or not (“Taxes”)
as of
the Closing Date. Except as set forth in Schedule
3.10-1,
the
Company has filed when due all required Tax reports and returns in connection
with and in respect of its business, assets and employees, and has timely paid
and discharged all amounts shown as due thereon. Except as set forth in
Schedule
3.10-2,
all
such Tax returns are true and complete in all material respects. The Seller
Parties have made available to Buyer accurate and complete copies of all of
the
Company’s Tax reports and returns for all periods, except those periods for
which returns are not yet due. To each Seller Party’s knowledge, there are no,
and there is no basis for any, pending or threatened claims, assessments,
notices, deficiencies or audits with respect to any Taxes owed or allegedly
owed
by the Company. The Company has not received any notice of any Tax deficiency
outstanding, proposed or assessed against or allocable to it, and has not
executed any waiver of any statute of limitations on the assessment or
collection of any Tax or executed or filed with any Governmental Body any
Contract now in effect extending the period for assessment or collection of
any
Taxes against it. Except for Permitted Encumbrances (as defined in Section
3.11),
there
are no Encumbrances for Taxes upon, or pending or threatened against, the
Company. The Company is not subject to any Tax allocation or sharing Contract.
The Company (i) has not been a member of an “affiliated group” filing a
consolidated federal income Tax return and (ii) has no liability or obligation
for the Taxes of any other person under the Code or any regulations promulgated
thereunder, as a transferee or successor, by Contract, or
otherwise.
3.11 Title
to, Sufficiency and Condition of Assets. Set forth
on
Schedule
3.11 (a)
are
the
assets and properties of
the
Company
(the
“Company
Assets”)
which
constitute and include all the assets necessary for the conduct of the Company’s
business as currently conducted, (b) there are no material assets used in or
relied upon for the conduct of the Company’s business other than the Company
Assets, (c) the Company has (and subject to Buyer’s own actions after the
Closing, Buyer will have) good, marketable and indefeasible title to, or a
valid
leasehold interest in, all of the Company Assets, in each case free and clear
of
any Encumbrances other than (i) statutory, mechanics’ or other liens that were
incurred in Company’s Ordinary Course of Business, (ii) Encumbrances that
are being contested in good faith and which have been disclosed to Buyer, (iii)
liens for Taxes incurred but not yet due and (iv) Encumbrances set forth on
Schedule
3.11
(collectively, “Permitted
Encumbrances”)
and
(d) all tangible assets included as part of the Company Assets, whether owned
or
leased, are free from material defects (patent and latent), have been maintained
in accordance with normal industry practice, are in good operating condition
(subject to normal wear and tear) and are suitable for the purposes for which
they are currently used and currently proposed to be used.
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
7
3.12 Real
Property.
Except
as set forth on Schedule
3.12,
the
Company does not own or lease any real property.
3.13 Intellectual
Property.
As used
in this Agreement, “Intellectual
Property”
means
any rights, licenses, charges, Encumbrances, equities and other claims that
any
person may have to claim ownership, authorship or invention of, to use, to
object to or prevent the modification of or to withdraw from circulation or
control the publication or distribution of, any: (a) copyrights in both
published works and unpublished works, (b) fictitious business names, trading
names, corporate names, registered and unregistered trademarks, service marks
and applications, (c) any (i) patents and patent applications and (ii) business
methods, inventions and discoveries that may be patentable, (d) computer
software or middleware and (e) know-how, trade secrets, confidential
information, customer lists, software (source code and object code), technical
information, data, process technology, plans, drawings and blue prints. Except
as set forth in Schedule
3.13,
the
Company owns, or possesses legally enforceable rights to use, all Intellectual
Property used in its business as currently, or as currently proposed to be,
conducted by the Company. The Company’s use of the Intellectual Property in its
business as currently conducted (and the operation of its business) does not,
and the use of such Intellectual Property by the Company and its Affiliates
after Closing (subject to Buyer’s own actions after the Closing) will not,
infringe, violate or constitute misappropriation of any rights any other person
owns or holds.
3.14 Inventory.
The
Company’s sole inventory consists of finished goods purchased from Buyer
pursuant to the terms of that certain Consulting, Services and Purchasing
Agreement by and between Buyer and the Company dated November 1, 2006, as
amended (the “CSP
Agreement”).
3.15 Contracts. Schedule
3.15
lists
each Contract to which the Company is a party. The Company has delivered to
Buyer a correct and complete copy of each written Contract (as amended to date)
listed in Schedule
3.15
and a
written summary setting forth the terms and conditions of each oral Contract
referred to in Schedule
3.15.
Except
as
set forth on Schedule
3.15,
each
such
Contract is legal, valid and enforceable and will continue to be legal, valid
and enforceable on identical terms following the consummation of the
Transactions. Except
as
set forth in Schedule
3.15,
neither
the
Company nor, to each Seller Party’s knowledge, any of the counter-parties to any
such Contract is or has been in (and no event has occurred that, with or without
notice or lapse of time, would create or constitute a) breach or violation
of,
or default under, any of such Contract’s provisions, no event has occurred or
likely to occur that, with or without notice or lapse of time, would give the
Company or any other party to any Contract the right to either (i) declare
a
default or exercise any remedy under such Contract, (ii) accelerate the
performance of, or payment under, such Contract or (iii) cancel, terminate
or
modify any such Contract. To each Seller Party’s knowledge, no party to any
Contract has repudiated any provision of the Contract. Schedule
3.15
also
denotes each such Contract to which Seller or any of its Affiliates is a
party.
3.16 Receivables.
All of
the Company’s receivables, including all Contracts in transit, manufacturers
warranty receivables, notes receivable, accounts receivable, trade account
receivables, and insurance proceeds receivable (“Receivables”)
with
respect to sales of Spine Products (****)
as of
December 26, 2007 are set forth on Schedule
3.16.
All of
the Receivables as of the Closing Date are valid and enforceable, represent
bona
fide transactions, arose in the Company’s Ordinary Course of Business and are
reflected on the Company’s books and records. Except as set forth on
Schedule
3.16,
all of
the Receivables as of the Closing Date are good and collectible receivables,
are
current and will be collected in accordance with past practice without any
set
off, valid defense or counterclaims. No customer or supplier of the Company
is
entitled to any payment terms.
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
8
3.17 Litigation. Schedule
3.17
sets
forth each instance in which the Company (a) is subject to any outstanding
Order
or (b) is a party to, the subject of or, to any Seller Party’s knowledge,
threatened to be made a party to or the subject of, any action, appeal,
petition, plea, charge, complaint, claim, suit, demand, litigation, arbitration,
mediation, hearing, inquiry, investigation or similar event, occurrence,
or
proceeding. No Order or Action required to be set forth in Schedule
3.17
questions the validity or enforceability of any Transaction Document or any
Transaction, or could result in any material adverse effect on the Company,
and
no Seller Party has any basis to believe that any such Action may be brought
or
threatened against the Company.
3.18 Insurance. Schedule
3.18
contains
accurate and complete (i) lists of all insurance policies currently carried
by
the Company, (ii) lists of all insurance loss runs or workers’ compensation
claims received for the past three policy years, and (iii) copies of all
insurance policies currently in effect. Such insurance policies evidence all
of
the insurance that the Company is required to carry pursuant to its Contracts
and Law. Such insurance policies are currently in full force and effect and
will
remain in full force and effect through their current terms. No insurance that
the Company has ever carried has been canceled nor has any such cancellation
been, to any Seller Party’s knowledge, threatened. The Company has never been
denied coverage nor has any such denial been, to any Seller Party’s knowledge,
threatened.
3.19 Intentionally
Omitted.
3.20 Employee
Benefits. The
Company does not maintain any non-qualified
deferred compensation plan, qualified defined contribution retirement plan,
qualified defined benefit retirement plan or other material fringe benefit
plan
or program or to which the Company contributes.
3.21 Intentionally
Omitted.
3.22 Permits. Except
as
set forth on Schedule
3.22,
the
Company
possesses all Permits required to be obtained for its businesses and operations.
Schedule
3.22
sets
forth a list of all such Permits. Except as set forth in Schedule
3.22,
with
respect to each such Permit: (a) it is valid, subsisting and in full force
and
effect; (b) there are no violations of such Permit that would result in a
termination of such Permit; (c) the Company has not received notice that such
Permit will not be renewed; and (d) the Transactions will not adversely affect
the validity of such Permit or cause a cancellation of or otherwise adversely
affect such Permit.
3.23 Customers;
Suppliers.
There
have been no customers, resellers, licensees and distributors of the Company
that ordered goods and services from the Company with an aggregate value for
each such customer of $50,000 or more during the twelve-month period ended
November 30, 2007. The Company has not engaged in any “channel stuffing” or
similar practices that could have the effect of accelerating revenue from a
customer into a current period which will cause a significant reduction of
revenue in a future period.
3.24 Accuracy
of Information Furnished.
No
representation, statement or information contained in this Agreement, any of
the
Transaction Documents or any Contract or other document made available or
furnished to Buyer or its representatives by any Seller Party is known to
contain any untrue statement of a material fact or to omit any material fact
necessary to make the information contained therein not misleading.
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
9
ARTICLE
4
COVENANTS
4.1 General.
If any
time after the Closing any further action is necessary or desirable to
effectuate the Transactions as contemplated by this Agreement, each Party will
take such further action (including executing and delivering any further
instruments and documents, obtaining any Permits and consents and providing
any
reasonably requested information) as any other Party may reasonably request,
all
at the requesting Party’s sole cost and expense (unless the requesting Party is
entitled to indemnification therefor under ARTICLE
5).
4.2 Confidentiality.
For a
period of five years following the Closing Date (except with respect to the
trade secrets of Company, for which the term of the covenant contained in this
Section
4.2
shall be
perpetual), Seller will, and will cause each of its respective Affiliates,
directors, officers, employees, agents, representatives and similarly situated
persons to (a) treat and hold as confidential, and not use or disclose, all
of
the information possessed by such person concerning the Company, its business,
the negotiation or existence and terms of this Agreement and the business
affairs of Buyer (“Confidential
Information”),
except for (i) disclosures to the person’s professional advisors, the actions
for which the disclosing person will be responsible, (ii) disclosures required
for such person to perform obligations it may have under this Agreement
or
in
enforcing its rights under this Agreement,
and
(iii) disclosures
required by applicable law or order and information that is available to the
public on the Closing Date or thereafter becomes available to the public other
than as a result of a breach of this Section
4.2,
and
(b)
deliver promptly to Buyer or destroy, at Buyer’s request and option, all
tangible embodiments (and all copies) of the Confidential Information which
are
in such person’s possession. If any person subject to these confidentiality
provisions is ever requested or required (by oral or written question or request
for information or documents in any Action) to disclose any Confidential
Information, Seller will notify Buyer promptly of the request or requirement
so
that Buyer may seek an appropriate protective Order or waive compliance with
this Section
4.2.
4.3 Restrictive
Covenants.
To
assure that Buyer will realize the benefits of the Transactions, Seller agrees
that it will not, and will ensure that each of its Affiliates does
not:
(a) From
the
Closing Date until five years after the Closing Date (the “Non-Compete
Termination Date”),
directly or indirectly, alone or as a partner, joint venturer, officer,
director, member, employee, consultant, agent or independent contractor of,
or
lender to, any person or business, engage in activities similar to or
competitive with the activities conducted by the Company anywhere
in the United States;
provided,
however,
that
the passive ownership of less than one
percent
of the
ownership interests of an entity having a class of securities that is traded
on
a national securities exchange or in the over-the-counter market is not a
violation of this Section
4.3(a).
(b) From
the
Closing Date until the Non-Compete Termination Date, directly or indirectly
(i)
solicit any customers of Buyer or any of its Affiliates for the benefit of
any
business directly or indirectly in competition with the business of Buyer or
any
of its Affiliates or (ii) request, advise or induce any person who is a
customer, employee, contractor, vendor or lessor of Buyer or any of its
Affiliates to withdraw, curtail or cancel the relationship such person has
with
Buyer or its Affiliate.
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
10
(c) From
the
Closing Date until the Non-Compete Termination Date, directly or indirectly,
for
itself or on behalf of another, solicit for employment or engagement as an
independent contractor, or for any other similar purpose, any person who was
in
the six-month period preceding the solicitation, or is at the time of the
solicitation, an employee or independent contractor of Buyer or any of Buyer’s
Affiliates,
other
than such person (i) whose employment or independent contractor relationship
was
terminated by Buyer or its Affiliate or (ii) who independently responded to
a
general solicitation for employment by such Seller or Seller
Affiliate.
Seller
acknowledges that the restrictions in this Section
4.3
are
reasonable in scope and duration and are necessary to protect Buyer after the
Closing. Seller acknowledge that Seller’s breach of this Section
4.3
will
cause irreparable damage to Buyer, and upon breach of any provision of this
Section
4.3,
Buyer
will be entitled to injunctive relief, specific performance or other equitable
relief without bond or other security; provided,
however,
that
the foregoing remedies will in no way limit any other remedies Buyer may
have.
4.4 Litigation
Support.
So long
as any Party actively is contesting or defending against any Action in
connection with (a) the Transactions or (b) any fact, situation, circumstance,
status, condition, activity, practice, plan, occurrence, event, incident,
action, failure to act, or transaction on or prior to the Closing Date involving
the Company, each other Party will cooperate with such Party and such Party’s
counsel in the contest or defense, make available their personnel, and provide
such testimony and access to their books and records as will be necessary in
connection with the contest or defense, at the sole cost and expense of the
contesting or defending Party (unless the contesting or defending Party or
one
of its Affiliates is entitled to indemnification therefor under ARTICLE
5).
4.5 Post-Closing
Cooperation.
(a)After
the
Closing, upon reasonable notice, Buyer shall furnish or cause to be furnished
to
Seller and his counsel, auditors and representatives, during normal business
hours, such information and assistance relating to the Company’s business (to
the extent within the control of Buyer) as is reasonably necessary
for
(i)
financial reporting and accounting matters;
(ii)
filing of all Tax returns
(including amended Tax Returns),
and
making any election related to Taxes, the preparation for, response to and
defense of any audit by any taxing authority; (iii)
the
prosecution or defense of any proceeding; and (iv)
the
conduct of any audit or other proceeding involving the Company’s business on or
prior to the Closing Date.
(b)Seller
shall prepare or cause to be prepared and file or cause to be filed all income
tax returns of Company that are filed after the Closing Date with respect to
all
taxable periods ending on or before the Closing Date.
(c) Buyer
shall provide such financial information that is necessary and appropriate
to
enable Seller Parties to prepare and file their local, state and federal income
Tax returns for the Tax year that includes the Closing Date.
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
11
(d) Buyer
shall retain all records, schedules, work papers and all other documents
relating to the Company’s business
in a
manner consistent with Buyer’s document retention policy.
(e) Buyer
shall pay to Seller the service fee
earned
by Company from December 1, 2007 through the Closing Date under the CSP
Agreement,
which
service fee shall be payable by Buyer to Seller on or before January 31,
2008.
(f) Following
the Closing Date, Buyer shall cause the Company to remit to Seller any payments
received by Company with respect to Seller’s Receivables within 10 business days
of the Company’s receipt thereof
(g) Following
the Closing Date, Seller shall use his reasonable best efforts to assist the
Company in obtaining the written consent of the Landlord (defined below) to
the
sale of the Shares by Seller to Buyer, as required by that
certain **** lease agreement dated June 8, 2007 (the “Lease”)
by and
between the Company and **** (the “Landlord”).
ARTICLE
5
INDEMNIFICATION
5.1 Survival
of Representations, Warranties and Covenants.
Each
representation and warranty of the Parties contained herein and any certificate
related to such representations and warranties will survive the Closing and
continue in full force and effect until the applicable statute of limitations
expires, except the representations and warranties set forth in Sections
2.1,
2.2(a),
2.2(b),
2.2(c),
3.1,
3.2
and
3.4,
which
will survive the Closing and will continue in full force and effect forever.
Each covenant and obligation in this Agreement, and any certificate or document
delivered pursuant to this Agreement, will survive the Closing forever. Unless
expressly waived pursuant to this Agreement, no representation, warranty,
covenant, right or remedy available to any person in connection with the
Transactions will be deemed waived by any action or inaction of that person
(including consummation of the Transactions, any inspection or investigation,
or
the awareness of any fact or matter) at any time, whether before, on or after
the Closing.
5.2 Indemnification
Provisions for Buyer’s Benefit.“Damages”
means
all losses (including diminution in value), damages and other costs and expenses
of any kind or nature whatsoever, whether known or unknown, contingent or
vested, matured or unmatured, and whether or not resulting from third-party
claims, including costs (including reasonable fees and expenses of attorneys,
other professional advisors and expert witnesses and the allocable portion
of
the relevant person’s internal costs) of investigation, preparation and
litigation in connection with any Action or threatened Action. The Seller
Parties, jointly and severally, will indemnify and hold Buyer and its
Affiliates, and their respective officers, directors, managers, employees,
agents, representatives, controlling persons, stockholders and similarly
situated persons (the “Buyer
Indemnified Parties”),
harmless from and pay any and all Damages directly or indirectly based upon,
resulting from, relating to, arising out of or attributable to any of the
following: (a) any breach of any representation or warranty any Seller Party
has
made in this Agreement; and (b) any breach, violation or default by any Seller
Party of any covenant, agreement or obligation of a Seller Party in this
Agreement.
5.3 Indemnification
Provisions for Seller Parties’ Benefit.
Buyer
will indemnify and hold each Seller Party and its Affiliates, and their
respective officers, directors, managers, employees, agents, representatives,
controlling persons, stockholders and similarly situated persons (the
“Seller
Indemnified Parties”
and
together with the Buyer Indemnified Parties, the “Indemnified
Parties”),
harmless from and pay any and all Damages directly or indirectly, based upon,
resulting from, relating to, arising out of or attributable to any of the
following: (a) any breach of any representation or warranty Buyer has made
in
this Agreement; and (b) any breach, violation or default by Buyer of any
covenant, agreement or obligation of Buyer in this Agreement.
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
12
5.4 Indemnification
Claim Procedures.
(a) If
any
Action
is
commenced or
threatened
that may
give rise to a claim for indemnification (an “Indemnification
Claim”)
by a
Seller Indemnified Party, then such Seller Indemnified Party will promptly
give
notice to Buyer. Failure to notify Buyer will not relieve Buyer of any liability
that it may have to the Seller Indemnified Party, except to the extent the
defense of such Action
is
materially and irrevocably prejudiced by the Seller Indemnified Party’s failure
to give such notice. Buyer may elect, its
sole
cost and expense,
to
assume and thereafter conduct the defense of the Indemnification Claim with
counsel of Buyer’s choice reasonably satisfactory to the Seller Indemnified
Party; provided,
however,
that
Buyer shall
have acknowledged in writing Buyer’s unqualified obligation to indemnify the
Seller Indemnified Parties as provided hereunder; and
provided, further
than
Buyer will
not
approve of the entry of any judgment or enter into any settlement or
other
resolution with
respect to the Indemnification Claim without the Seller Indemnified Parties’ prior
written approval (which may
not be
withheld unreasonably). Until Buyer assumes the defense of the Indemnification
Claim, the Seller Indemnified Party may defend,
negotiate, settle or otherwise deal with
the
Indemnification Claim in any manner the Seller Indemnified Party
reasonably deems appropriate.
If the
Buyer shall assume the defense of any Indemnification Claim, a Seller
Indemnified Party may participate, at his or its own expense, in the defense
of
such Indemnification Claim; provided, however, that such Seller Indemnified
Party shall be entitled to participate in any such defense with separate counsel
at the expense of the Buyer if (i) so requested by the Buyer to participate
or
(ii) in the reasonable opinion of counsel to the Buyer, a conflict or potential
conflict exists between the Seller Indemnified Party and the Buyer that would
make such separate representation advisable; and
provided, further,
that
the Buyer shall not be required to pay for more than one such counsel (plus
any
appropriate local counsel) for all Seller Indemnified Parties in connection
with
any such Indemnification Claim. The Parties hereto agree to provide reasonable
access to the other to such documents and information as may be reasonably
requested in connection with the defense, negotiation or settlement of any
such
Indemnification Claim. Notwithstanding anything contained in this Section 5.4
to
the contrary, the Buyer shall not without the written consent of the Seller
Indemnified Party, settle or compromise any Indemnification Claim or permit
a
default or consent to entry of any judgment unless the claimant or claimants
and
Buyer provide to the Seller Indemnified Party an unqualified release from all
liability in respect of such Indemnification Claim. After any final decision,
judgment or award shall have been rendered by the applicable Governmental Body
of competent jurisdiction and the expiration of the time in which to appeal
therefrom, or a settlement shall have been consummated, or the Seller
Indemnified Party and Buyer shall have reached an agreement, in each case with
respect to an Indemnification Claim hereunder, the Seller Indemnified Party
shall forward to the Buyer notice of any sums due and owing by the Buyer
pursuant to this Section
5.4
with
respect to such matter and Buyer shall pay all of such sums so due and owing
to
the Seller Indemnified Party in accordance with Section
5.4(a)
by wire
transfer of immediately available funds within five (5) business days after
the
date of such notice.
If the
Seller Indemnified Party gives Buyer notice of an Indemnification Claim and
Buyer does not, within ten (10) days after such notice is given, give notice
to
the Seller Indemnified Party of its election to assume the defense of such
Indemnification Claim and thereafter promptly assume such defense, then Buyer
will be bound by any judicial determination made with respect to such
Indemnification Claim or any compromise or settlement of such Indemnification
Claim effected by the Seller Indemnified Party.
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
13
(b) If
any
Action
is
commenced or
threatened
that may
give rise to an Indemnification
Claim
by a
Buyer Indemnified Party, then such Buyer Indemnified Party will promptly give
notice to
Seller
Parties. Failure to notify
Seller
Parties will not relieve Seller
Parties of any liability that it may have to the Buyer
Indemnified Party, except to the extent the defense of such Action
is
materially and irrevocably prejudiced by the
Buyer
Indemnified Party’s
failure to give such notice. Seller may elect,
at
his
sole
cost and expense, to assume and thereafter conduct
the
defense of the Indemnification Claim with counsel of Seller’s choice reasonably
satisfactory to the Buyer Indemnified Party;
provided,
however,
that
Seller shall have acknowledged in writing Seller’s unqualified obligation to
indemnify the Buyer Indemnified Parties as provided hereunder; and
provided, further
than
Seller will not approve of the entry of any judgment or enter into any
settlement or other resolution with respect to the Indemnification Claim without
the Buyer Indemnified Parties’ prior written approval (which must not be
withheld unreasonably). Until Seller assumes the defense of the Indemnification
Claim, the
Buyer
Indemnified Party may defend,
negotiate, settle or otherwise deal with
the
Indemnification Claim in any manner the
Buyer
Indemnified Party reasonably deems
appropriate. If the Seller shall assume the defense of any Indemnification
Claim, a Buyer Indemnified Party may participate, at his or its own expense,
in
the defense of such Indemnification Claim; provided, however, that such Buyer
Indemnified Party shall be entitled to participate in any such defense with
separate counsel at the expense of the Seller if (i) so requested by the Seller
to participate or (ii) in the reasonable opinion of counsel to the Seller,
a
conflict or potential conflict exists between the Buyer Indemnified Party and
the Seller that would make such separate representation advisable; and
provided, further,
that
the Seller shall not be required to pay for more than one such counsel (plus
any
appropriate local counsel) for all Buyer Indemnified Parties in connection
with
any such Indemnification Claim. The Parties hereto agree to provide reasonable
access to the other to such documents and information as may be reasonably
requested in connection with the defense, negotiation or settlement of any
such
Indemnification Claim. Notwithstanding anything contained in this Section
5.4
to the
contrary, the Seller shall not without the written consent of the Buyer
Indemnified Party, settle or compromise any Indemnification Claim or permit
a
default or consent to entry of any judgment unless the claimant or claimants
and
Seller provide to the Buyer Indemnified Party an unqualified release from all
liability in respect of such Indemnification Claim. After any final decision,
judgment or award shall have been rendered by the applicable Governmental Body
of competent jurisdiction and the expiration of the time in which to appeal
therefrom, or a settlement shall have been consummated, or the Buyer Indemnified
Party and Seller shall have reached an agreement, in each case with respect
to
an Indemnification Claim hereunder, the Buyer Indemnified Party shall forward
to
the Seller notice of any sums due and owing by the Seller pursuant to this
Section 5.4 with respect to such matter and Seller shall pay all of such sums
so
due and owing to the Buyer Indemnified Party in accordance with Section
5.4(b)
by wire
transfer of immediately available funds within five (5) business days after
the
date of such notice. If the Buyer Indemnified Party gives Seller notice of
an
Indemnification Claim and Seller does not, within ten (10) days after such
notice is given, give notice to the Buyer Indemnified Party of its election
to
assume the defense of such Indemnification Claim and thereafter promptly assume
such defense, then Seller will
be
bound by any judicial determination made with respect to such Indemnification
Claim or any compromise or settlement of such Indemnification Claim effected
by
the Buyer Indemnified Party.
(c) A
claim
for any matter not involving a third party may be asserted by notice to the
Party from whom indemnification is sought.
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
14
5.5 Limitations
on Indemnification Liability.
Any
claims an Indemnified Party makes under this ARTICLE
5
will be
limited as follows: Buyer, on the one hand, and the Seller Parties on the other,
will have no liability for money Damages related to breaches of the
representations and warranties in Section
2.2
(with
respect to Buyer) or Section
2.1
and
ARTICLE
3
(with
respect to the Seller Parties), unless and until the aggregate Damages related
thereto exceed $****;
provided,
however,
that,
once
aggregate Damages exceed such amount, the applicable Indemnified Parties will
be
entitled to recover all amounts to which they are entitled in excess of the
amount set forth above in this Section 5.5.
Notwithstanding
anything contained in this Agreement to the contrary, including, without
limitation this ARTICLE
5,
any
payment that Seller is obligated to make to a Buyer Indemnified Party pursuant
to the provisions of this ARTICLE
5
or
otherwise and any personal liability of Seller (in each case except to the
extent arising from breaches
of Sections
2.1,
3.1,
3.2,
3.4,
4.1,
4.2,
and
4.4
or
instances of fraud by any Seller Party)
shall be
paid and satisfied solely out of the Escrow Fund (as defined in Section
5.6)
or
offset by Buyer against any payments that might be due to Seller under
Section
6.1.
5.6 Escrow.
Immediately
after Closing, $**** (the “Escrow
Amount”)
will
be placed in an escrow fund (the “Escrow
Fund”)
for a
term of twenty-four (24) months pursuant to an escrow agreement (the
“Escrow
Agreement”)
by and
among Buyer, Seller and Well Fargo Bank, N.A. (the
“Escrow
Agent”)
dated
as of the date of this Agreement and entered into in connection herewith. The
Escrow Fund will be available to compensate the Buyer Indemnified Parties for
Damages. The Escrow Fund will be paid out in accordance with the terms of the
Escrow Agreement. An Indemnified Buyer Party may not receive any assets from
the
Escrow Fund unless and until an Officer’s Certificates (as defined in the Escrow
Agreement) identifying the relevant Damages have been delivered to the Escrow
Agent as provided in the Escrow Agreement. Neither the exercise of nor failure
to exercise its rights under this Section
5.6
will
constitute an election of remedies or limit Buyer in any matter in the
enforcement of any other remedies available to it.
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
15
ARTICLE
6
EARN
OUT
6.1 Earn
Out Payments.
(a) Subject
to the terms of this ARTICLE
6,
Buyer
will pay to Seller, as additional consideration for the Shares, the amounts
set
forth in this Section
6.1.
All
payments to be made pursuant to this Section
6.1
will be
paid in
cash
by wire
transfer of immediately available funds. All calculations required by this
Section
6.1
will be
made by Company and delivered to Seller. At the time of each such payment,
Buyer
shall provide a computation of the amounts payable under this Article
6,
and
Seller will have the right to communicate with, and to review the work papers,
schedules, memoranda, and other documents Buyer prepared or reviewed in
determining any of the amounts payable under this Section
6.1.
(b) In
the
event that, within one year of the Closing Date, any **** of the private health
care insurers listed on Exhibit
A
attached
hereto agree in writing to make routine payments to Company or its Affiliates
for any surgical procedures involving the use of any Spine Products (as defined
below) in the United States, except with respect to Medicare and Medicaid and
with respect to No Carve Out Cases (as defined in the CSP Agreement) and,
pursuant to such written agreement, the amount to be reimbursed for such
Coblation device exceeds in each case at least $****, then, on the first
anniversary of the Closing Date, Buyer shall pay to Seller an amount equal
to
$****. Buyer shall promptly notify Seller if any health care insurers listed
on
Exhibit A agree to make such payments.
(c) In
the
event that no Seller Party has breached its obligations under Section
4.3
of this
Agreement prior to then Non-Compete Termination Date, then, on the Non-Compete
Termination Date, Buyer shall pay to Seller an amount equal to
$****.
(d) On
the
second anniversary of the Closing Date, Buyer shall pay to Seller an amount
equal to the sum of: (i) ****% of the total dollar amount of the Public Health
Insurance Receivables of the Company on the Closing Date that are collected
by
Buyer during the one-year period following the Closing Date, and (ii) ****%
of
the total dollar amount of the Public Health Insurance Receivables arising
in
the United States after the Closing Date and collected by Company or its
Affiliates during the two-year period following the Closing Date under the
“DiscoCare” tradename. For the purposes of this Agreement, “Public
Health Insurance Receivables”
means
all Spine Product Receivables from sales in the United States from all payors,
excluding ****, and “Spine
Product(s)”
means
those products of the Company listed on Exhibit
B
attached
hereto, including any further replacements for such products.
(e) In
the
event that Public Health Insurance Net Revenue in the United States of the
Company associated with the Spine Products (the “Revenue
Subset”)
exceeds $**** million (the “Threshold”)
in any
fiscal year of Company ending prior to January 1, 2012 (the “Initial
Threshold Year”),
then,
within 45 days after the end of the Initial Threshold Year, Company shall pay
to
Seller an amount equal to (i) ****% times the amount that the Revenue Subset
for
the Initial Threshold Year exceeds the Threshold, up to a maximum of ****%
of
the Threshold, plus (ii) ****% times the amount that the Revenue Subset exceeds
****% of the Threshold. For the purposes of this Agreement, “Public
Health Insurance”
means
all payors, excluding ****, and “Net
Revenue”
means
such amount determined in accordance with GAAP as invoiced amount minus charges
for handling, freight, taxes, C.O.D. charges, insurance, tariffs and duties,
cash and trade discounts, rebates, amounts allowed or credited for returns,
uncollected or uncollectable amounts, services, and the like.
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
16
(f) In
the
event that during Company’s fiscal year immediately following the Initial
Threshold Year (the “Second
Threshold Year”),
if
any, Buyer will pay to Seller, within 45 days of the end of the Second Threshold
Year, an amount equal to: (i) ****% times the amount that the Revenue Subset
for
the Second Threshold Year exceeds the lesser of $**** million or the Revenue
Subset during the Initial Threshold Year (the “Second
Threshold”),
up to
a maximum of ****% of the Second Threshold, plus (ii) ****% times the amount
that the Revenue Subset for the Section Threshold Year exceeds ****% of the
Second Threshold.
(g) In
the
event that during Company’s fiscal year immediately following the Second
Threshold Year (the “Third
Threshold Year”),
if
any, Company will pay to Seller, within 45 days of the end of the Third
Threshold Year, an amount equal to: (i) ****% times the amount that the Revenue
Subset for the Third Threshold Year exceeds the lesser of $**** million or
the
Revenue Subset during the Second Threshold Year (the “Third
Threshold”),
up to
a maximum of ****% of the Third Threshold, plus (ii) ****% times the amount
that
the Revenue Subset for the Third Threshold Year exceeds ****% of the Third
Threshold.
6.2 Resolution
of Conflicts. If
Buyer
and Seller are unable to agree on an amount to be paid pursuant to this
Article
6,
then
(A) for twenty (20) days after the date Buyer receives a letter from Seller
detailing its objections to Company’s calculations of such amount, Seller and
Buyer will use their reasonable good-faith efforts to agree on such calculation,
and (b) lacking such agreement, the matter will be referred to a mutually
acceptable independent accounting firm, which will determine the correct amount
within sixty (60) days of such referral, which determination will be final
and
binding on the Parties for all purposes
6.3 Offset. Buyer,
acting in good faith, will have the option of setting off all or any part of
any
Damages a Buyer Indemnified Party suffers by notifying Seller that Buyer is
reducing the amount of any payment due to Seller under Section
6.1
by the
amount of such Damages.
ARTICLE
7
MISCELLANEOUS
7.1 Entire
Agreement.
This
Agreement, together with the other Transaction Documents and all schedules,
exhibits, annexes or other attachments hereto or thereto, and the certificates,
documents, instruments and writings that are delivered pursuant hereto or
thereto, constitutes the entire agreement and understanding of the Parties
in
respect of the subject matter hereof and supersedes all prior understandings,
agreements or representations by or among the Parties, written or oral, to
the
extent they relate in any way to the subject matter hereof. Except as provided
in ARTICLE
5,
there
are no third party beneficiaries having rights under or with respect to this
Agreement.
7.2 Assignment;
Binding Effect.
No Party
other than Buyer may assign either this Agreement or any of its rights,
interests or obligations hereunder without the prior written approval of the
other Parties, and any such assignment by a Party without prior written approval
of the other Parties will be deemed invalid and not binding on such other
Parties. All of the terms, agreements, covenants, representations, warranties
and conditions of this Agreement are binding upon, inure to the benefit of
and
are enforceable by, the Parties and their respective successors and permitted
assigns.
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
17
7.3 Notices.
All
notices, requests and other communications provided for or permitted to be
given
under this Agreement must be in writing and must be given by personal delivery,
by certified or registered United States mail (postage prepaid, return receipt
requested), by a nationally recognized overnight delivery service for next
day
delivery, or by facsimile transmission, to the intended recipient at the address
set forth for the recipient on the signature page (or to such other address
as
any Party may give in a notice given in accordance with the provisions hereof).
All notices, requests or other communications will be effective and deemed
given
only as follows: (i) if given by personal delivery, upon such personal delivery,
(ii) if sent by certified or registered mail, on the fifth business day after
being deposited in the United States mail, (iii) if sent for next day delivery
by overnight delivery service, on the date of delivery as confirmed by written
confirmation of delivery or (iv) if sent by facsimile, upon the transmitter’s
confirmation of receipt of such facsimile transmission, except that if such
confirmation is received after 5:00 p.m. (in the recipient’s time zone) on a
business day, or is received on a day that is not a business day, then such
notice, request or communication will not be deemed effective or given until
the
next succeeding business day. Notices, requests and other communications sent
in
any other manner, including by electronic mail, will not be
effective.
7.4 Specific
Performance; Remedies.
Each
Party acknowledges and agrees that the other Parties would be damaged
irreparably if any provision of this Agreement were not performed in accordance
with its specific terms or were otherwise breached. Accordingly, the Parties
will be entitled to an injunction or injunctions to prevent breaches of the
provisions of this Agreement and to enforce specifically this Agreement and
its
provisions in any action or proceeding instituted in any
state
or federal court sitting in Xxxxxx County, Texas having
jurisdiction over the Parties and the matter, in addition to any other remedy
to
which they may be entitled, at law or in equity. Except as expressly provided
herein, the rights, obligations and remedies created by this Agreement are
cumulative and in addition to any other rights, obligations or remedies
otherwise available at law or in equity. Nothing herein will be considered
an
election of remedies.
7.5 Headings.
The
article and section headings contained in this Agreement are inserted for
convenience only and will not affect in any way the meaning or interpretation
of
this Agreement.
7.6 Governing
Law.
This
Agreement will be governed by and construed in accordance with the laws of
the
State of Texas, without giving effect to
any
choice of law principles.
7.7 Resolution
of Conflicts and Arbitration.
(a)Except
as
otherwise provided herein, all disputes arising under this Agreement
(“Arbitration
Disputes”)
will
be resolved as follows: first, senior management of Buyer and Seller will meet
to attempt to resolve such Arbitration Dispute. If the Arbitration Dispute
cannot be resolved by agreement of the Parties, any Party may at anytime make
a
written demand for binding arbitration of the Arbitration Dispute in accordance
with this Section
7.7;
provided that the foregoing will not preclude equitable or other judicial relief
to enforce the provisions hereof or to preserve the status quo pending
resolution of Arbitration Disputes; and provided further and subject to
Section
7.7
that
resolution of Arbitration Disputes with respect to claims by third Persons
will
be deferred until any judicial proceedings with respect thereto are concluded.
All Arbitration Disputes shall be settled by arbitration conducted by one
arbitrator. Buyer and Seller shall agree on the arbitrator, provided that if
Buyer and Seller cannot agree on such arbitrator, either Buyer or Seller can
request that Judicial Arbitration and Mediation Services (“JAMS”)
select
the arbitrator. The arbitrator shall set a limited time period and establish
procedures designed to reduce the cost and time for discovery while allowing
the
parties an opportunity, adequate in the sole judgment of the arbitrator, to
discover relevant information from the opposing parties about the subject matter
of the dispute. The arbitrator shall rule upon motions to compel or limit
discovery and shall have the authority to impose sanctions, including attorneys’
fees and costs, to the same extent as a court of competent law or equity, should
the arbitrator determine that discovery was sought without substantial
justification or that discovery was refused or objected to without substantial
justification. The decision of the arbitrator shall be written, shall be in
accordance with applicable law and with this Agreement, and shall be supported
by written findings of fact and conclusion of law which shall set forth the
basis for the decision of the arbitrator. The decision of the arbitrator as
to
the validity and amount of any Damages shall be binding and conclusive upon
the
parties to this Agreement, and the Escrow Agent and the parties shall be
entitled to act in accordance with such decision and the Escrow Agent shall
be
entitled to make or withhold payments out of the Escrow Fund in accordance
therewith.
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
18
(b)Judgment
upon any award rendered by the arbitrator may be entered in any court having
jurisdiction. Any such arbitration shall be held in Xxxxxx County, Texas under
the commercial rules then in effect of JAMS. The non-prevailing party to an
arbitration shall pay its own expenses, the fees of the arbitrator, any
administrative fee of JAMS, and the expenses, including attorneys’ fees and
costs, reasonably incurred by the other party to the arbitration. For purposes
of this Section
7.7,
the
party seeking indemnification shall be deemed to be the non-prevailing party
unless the arbitrator awards the party seeking indemnification more than 50%
of
the amount in dispute, plus any amounts not in dispute; otherwise, the person
against whom indemnification is sought shall be deemed to be the non-prevailing
party.
7.8 Amendment;
Extensions; Waivers.
No
amendment, modification, waiver, replacement, termination or cancellation of
any
provision of this Agreement will be valid, unless the same is in writing and
signed by all of the Parties. Each waiver of a right hereunder does not extend
beyond the specific event or circumstance giving rise to the right. No waiver
by
any Party of any default, misrepresentation or breach of warranty or covenant
hereunder, whether intentional or not, may be deemed to extend to any prior
or
subsequent default, misrepresentation or breach of warranty or covenant
hereunder or affect in any way any rights arising because of any prior or
subsequent such occurrence. Neither the failure nor any delay on the part of
any
Party to exercise any right or remedy under this Agreement will operate as
a
waiver thereof, nor does any single or partial exercise of any right or remedy
preclude any other or further exercise of the same or of any other right or
remedy.
7.9 Severability.
The
provisions of this Agreement will be deemed severable and the invalidity or
unenforceability of any provision will not affect the validity or enforceability
of the other provisions hereof; provided,
however,
that if
any provision of this Agreement, as applied to any Party or to any circumstance,
is judicially determined not to be enforceable in accordance with its terms,
the
Parties agree that the court judicially making such determination may modify
the
provision in a manner consistent with its objectives such that it is
enforceable, and/or to delete specific words or phrases, and in its modified
form, such provision will then be enforceable and will be enforced.
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
19
7.10 Expenses.
Except
as otherwise expressly provided in this Agreement, each Party will bear its
own
costs and expenses incurred in connection with the preparation, execution and
performance of this Agreement and the Transactions, including all fees and
expenses of agents, representatives, financial advisors, legal counsel and
accountants.
7.11 Counterparts;
Effectiveness.
This
Agreement may be executed in one or more counterparts, each of which will be
deemed an original but all of which together will constitute one and the same
instrument. This Agreement will become effective when one or more counterparts
have been signed by each Party and delivered to the other Parties. For all
purposes of this Agreement, a facsimile signature shall be deemed an original
signature.
7.12 Construction.
This
Agreement has been freely and fairly negotiated among the Parties. If an
ambiguity or question of intent or interpretation arises, this Agreement will
be
construed as if drafted jointly by the Parties and no presumption or burden
of
proof will arise favoring or disfavoring any Party because of the authorship
of
any provision of this Agreement. Any reference to any law will be deemed to
refer to such law as
amended
and all
rules and regulations promulgated thereunder, unless the context requires
otherwise. The words “include,” “includes,” and “including” will be deemed to be
followed by “without limitation.” The word “person” includes individuals,
entities and Governmental Bodies. Pronouns in masculine, feminine and neuter
genders will be construed to include any other gender, and words in the singular
form will be construed to include the plural and vice versa, unless the context
otherwise requires. The words “this Agreement,” “herein,” “hereof,” “hereby,”
“hereunder,” and words of similar import refer to this Agreement as a whole and
not to any particular subdivision unless expressly so limited. The Parties
intend that each representation, warranty and covenant contained herein will
have independent significance. If any Party has breached any representation,
warranty or covenant contained herein in any respect, the fact that there exists
another representation, warranty or covenant relating to the same subject matter
(regardless of the relative levels of specificity) which the Party has not
breached will not detract from or mitigate the fact that the Party is in breach
of the first representation, warranty or covenant.
7.13 Schedules.
The
disclosures in the schedules to this Agreement (the “Schedules”),
and
those in any supplement thereto, relate only to the representations and
warranties in the section or paragraph of the Agreement to which they expressly
relate and not to any other representation or warranty in this Agreement. If
there is any inconsistency between the statements in the body of this Agreement
and those in the Schedules (other than an exception expressly set forth in
the
Schedules with respect to a specifically identified representation or warranty),
the statements in the body of this Agreement will control. Nothing in the
Schedules will be deemed adequate to disclose an exception to a representation
or warranty made herein, unless the Schedules identify the exception with
reasonable particularity and describe the relevant facts in reasonable detail.
The mere listing (or inclusion of a copy) of a document or other item in a
Schedule will not be deemed adequate to disclose an exception to a
representation or warranty made in this Agreement (unless the representation
or
warranty pertains to the existence of the document or other item
itself).
[SIGNATURE
PAGES FOLLOW]
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
20
SIGNATURE
PAGE
TO
IN
WITNESS WHEREOF,
the
Parties have caused this Agreement to be executed as of the date stated in
the
introductory paragraph of this Agreement.
BUYER:
|
||
ARTHROCARE
CORPORATION
|
||
By:
/s/
Xxxx X. Raffle
|
||
Name: Xxxx X. Raffle | ||
Title:
Senior
Vice President, Strategic Business Units
|
||
Address: Building
Two
|
|
|
0000 Xxxxxx Xxxxxxxxx, Xxxxx 000 |
|
|
Xxxxxx XX 00000 |
|
|
COMPANY:
|
||
DISCOCARE,
INC.
|
||
By:
/s/
Xxxxxxxx Xxxxxx
|
||
Name:
Xxxxxxxx Xxxxxx, D.P.M.
|
||
Title:
President
|
||
Address: 0000
Xxxxx
Xxxx
|
|
|
Xxxxxxx,
XX
00000
|
|
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.
SIGNATURE
PAGE
TO
IN
WITNESS WHEREOF,
the
Parties have caused this Agreement to be executed as of the date stated in
the
introductory paragraph of this Agreement.
SELLER:
|
|
/s/
Xxxxxxxx Xxxxxx
|
|
Xxxxxxxx Xxxxxx, D.P.M. |
|
|
Address: 00000
Xxxxxxxxxx Xxxxxxxxx,
|
Xxxxx
X
|
|
Xxxxx
Xxxx
Xxxxx, XX 00000
|
|
****
Certain
information in this document has been omitted and filed separately with
the
Securities and Exchange Commission pursuant
to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and
the
Commission’s rules and regulations promulgated under the Freedom of Information
Act, pursuant to a request for confidential treatment.
Confidential treatment has been requested with respect to the omitted
portions.